Cerebrolysin for early stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if adding Cerebrolysin to standard rehabilitation helps people recover arm and hand function better after a first-time, moderate stroke. You may be eligible if you had a stroke and can follow simple instructions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had your first stroke (no prior stroke or disability)
- Your stroke was caused by a blood clot (ischemic stroke)
- Your stroke symptoms are moderate (NIHSS score between 6 and 12)
- You are able to perform the arm and hand function test (ARAT test)
- You are willing and able to give signed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called Cerebrolysin after a delayed procedure to remove a blood clot from the brain can help people recover from a severe stroke. It looks at people who have their clot removed more than 6 hours after symptoms start.
This trial tests whether adding cerebrolysin (a medication that may help repair brain cells) to the usual treatment improves recovery after a stroke in the basilar artery, which supplies the back of the brain. It is meant for people who have had this type of stroke and are otherwise fairly independent.
This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.
This study tests whether Cerebrolysin can improve recovery in people who remain in a vegetative or minimally conscious state more than 4 weeks after a bleeding stroke. It also tracks safety, to make sure the treatment is not causing harmful side effects.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
Hear when a new Rehabilitation Outcome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.